News

  • All
  • Cardiovascular
  • Central Nervous System
  • Gastroenterology
  • Syncrosome News
Join Syncrosome team at Nutrevent in Lille, France.

 Syncrosome invites you to visit us at Nutrevent, June 14th to 15th 2017, in Lille, France.Emmanuelle Bettendorf, our Business Developer would be delighted to meet you their and discuss your in vivo preclinical projects with a special offer dedicated to Nutraceutics, Food supplements and Natural...

A new therapeutic target to treat chronic inflammatory disease

Ulcerative Colitis is a chronic and relapsing inflammatory disease. Inflammation plays a major part in the symptoms of this disease that is characterized by pro-inflammatory cytokine production, leukocyte infiltration, and consequent structural and functional damage to the gut. There is still a lot that remains...

Evaluating preclinical emesis induced and nausea by PDE4 inhibitors

Emesis and/or Nausea are commonly reported side effects associated with several drugs such as 4 phosphodiesterase (PDE4) inhibitors and is a major drawback for the therapeutic use of these drugs. The mechanism responsible for this side effect has been investigated in an attempt to discover...

Meta analysis of mesenchymal stem cells in preclinical Parkinson models

Multiple studies have been performed to evaluate the effects of mesenchymal stem cells (MSCs) in preclinical Parkinson models.We performed a meta-analysis to estimate the treatment effect of unmodified MSCs on behavioral outcomes in preclinical studies of Parkinson's disease (PD). We performed a systematic literature search...

Syncrosome at the next Microbiome & Probotics Forum in Amsterdam

The 4th Microbiome R&D and Business collaboration Forum will feature 2 days of interactive presentations, poster presentation and networking opportunity, in Amsterdam (Netherlands) from 3 to 4th of April. This conference will offer a complete programme focusing on preclinical animal model and specific focuses :Probiotics and Digestive Health (Roles...

Nordic Day Syncrosome

The last january, all the Syncrosome laboratory an commercial team participated on a 2-day team building event in the French Alpes.It was an enthusiastic "scientific and sportive" experience for everyone!After different meetings to exchange on topics like:Important scientific and commercial results obtained in 2016, ...

Echocardiographic preclinical studies of Congestive heart failure

Congestive heart failure (CHF) is a serious outcome of myocardial infarction (MI). Animal models have been used to study various aspects of CHF. Postinfarction animal models have been extensively studied because myocardial ischemia and infarction are frequent causes of CHF in humans. However, not all...